Close Menu

NEW YORK – CareDx reported after the close of the market on Thursday that its second quarter revenues rose 76 percent year over year, thanks largely to an 84 percent increase in testing services revenues.

For the three months ended June 30, the molecular diagnostics company reported total revenues of $31.5 million, up from $17.8 million during the same period a year earlier, and beating the average Wall Street estimate of $28.0 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PLOS this week: Mycobacterium abscessus linked to gastric conditions, placental gene expression changes associated with preterm birth, and more.

The Guardian reports that UK universities are looking into ways to reduce labs' reliance on single-use plastics.

People with certain gene variants tend to not like vegetables, particularly bitter ones, CNN reports.

MIT's Technology Review reports on a company's genetic test that gauges an embryo's susceptibility to certain diseases.